Dana Farber Cancer Institute DFCI - Brookline

Boston, Massachusetts 02215

0 studies enrolling now · 3 studies all time

What they study most

Advanced Malignancies, Melanoma, Uveal Melanoma

Studies at this site

• Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies — Stopped early
• Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients — Completed
• A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation — Completed